No earnings forecast score is currently available for Indaptus Therapeutics Inc. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 10.00, with a high of 10.00 and a low of 10.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Indaptus Therapeutics Inc's price target?
Analysts forecast that Indaptus Therapeutics Inc's price target is USD 10.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 10.00.
How have Indaptus Therapeutics IncINDP's recent earnings per share performed?
The market expectation was USD -0.23, while Indaptus Therapeutics IncINDP's earnings per share (EPS) for the previous quarter was USD -4.51. EPS for the next quarter is expected at USD -1.57.